Phosphoricum Acidum Pellet
Product Images NDC 15631-0335

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Phosphoricum Acidum (NDC 15631-0335). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Pellets Fda 15631 0335

Label Pellets Fda 15631 0335
This is a description of a homeopathic medicine called Phosphoricum Acidum 3X. It contains Sucrose and is meant to provide temporary relief from debility. The recommended dosage is 4 to 6 pellets three times daily for adults and half of a dose for children over 2 years old. The medication should be used for self-limiting conditions only and users should seek professional advice if symptoms do not improve within 4 days. The medication should be kept away from children in a cool dark place and should not be used if the cap is broken or missing. There are 100 pellets in the container.*
FDA Label Image

Mini Labels Pellets Fda15631 0335

Mini Labels Pellets Fda15631 0335
This is a homeopathic medicine with the active ingredient being Phosphoricum Acidum 3X and the inactive ingredient being Sucrose. It is used for temporary relief of debility. The medicine comes in the form of pellets and the recommended dosage for adults is 4 pellets, three times a day or as directed by a physician. Children over 2 years old should take half of the adult dose. This product is not evaluated by the FDA and the claims are not supported by scientific evidence. The NDC number is 15631-0335 and the medicine is manufactured by an unknown company. Mini labels are used with blister packs for select pack sizes.*
FDA Label Image

Rxhomeo Secondary Packing Blister Pack

FDA Label Image

Rxhomeo Secondary Packing Carton Pack

Rxhomeo   Secondary Packing   Carton Pack
This is a description of a homeopathic medicine, manufactured according to the Homoeopathic Pharmacopoeia of the United States (HPUS). The warning section cautions that the product should not be used for self-limiting conditions and if symptoms do not improve after 4 days or worsen, users should discontinue use and seek assistance from a health professional. It further recommends consulting a professional before taking this product if pregnant or nursing. The medicine is distributed by Rehomeo, Inc and manufactured by Rihomeo Private Limited in India. The product is lactose-free and a single homeopathic remedy. However, some of the text is not readable due to errors.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.